VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications

By Suarez-Kurtz Guilherme   Amorim António   Damasceno Albertino   Hutz Mara H   Moraes Manuel Odorico de   Ojopi Élida B   Pena Sérgio DJ   Perini Jamila A   Prata Maria João   Ribeiro-dos-Santos Ândrea   Romano-Silva Marco A   Teixeira Daniel   Struchiner Claudio José  

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1257-1267

Future Medicine

Access to resources Recommend Favorite

VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update

By Eng Lawson   Liu Geoffrey  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1659-1667

Future Medicine

Access to resources Recommend Favorite

Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions

By Monteleone Palmiero   Maj Mario  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1487-1520

Future Medicine

Access to resources Recommend Favorite

Sirolimus Population Pharmacokinetic/Pharmacogenetic Analysis and Bayesian Modelling in Kidney Transplant Recipients

By Djebli Nassim  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1135-1148

Adis International

Access to resources Recommend Favorite

Evaluating a newly developed pharmacogenetic array: screening in a Spanish population

By Almoguera Berta   Riveiro-Alvarez Rosa   Gomez-Dominguez Belen   Lopez-Rodriguez Rosario   Dorado Pedro   Vaquero-Lorenzo Concepción   Dal-Ré Rafael   Fernandez-Piqueras Jose   LLerena Adrián   Abad-Santos Francisco   Ayuso Carmen  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1619-1625

Future Medicine

Access to resources Recommend Favorite